- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour macrophages as potential targets of bisphosphonates
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 9, Issue 1, Pages 177
Publisher
Springer Nature
Online
2011-10-18
DOI
10.1186/1479-5876-9-177
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elusive Identities and Overlapping Phenotypes of Proangiogenic Myeloid Cells in Tumors
- (2010) Seth B. Coffelt et al. AMERICAN JOURNAL OF PATHOLOGY
- Bisphosphonates in the treatment of metabolic bone diseases
- (2010) Henrique Pierotti Arantes et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
- (2010) J D Veltman et al. BRITISH JOURNAL OF CANCER
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Bisphosphonates in breast cancer: teaching an old dog new tricks
- (2010) Matthew C Winter et al. CURRENT OPINION IN ONCOLOGY
- Self-assembly nanoparticles for the delivery of bisphosphonates into tumors
- (2010) G. Salzano et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
- (2010) MP Coleman et al. LANCET
- Regulation of macrophage function in tumors: the multifaceted role of NF- B
- (2009) T. Hagemann et al. BLOOD
- GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells
- (2009) Johanna K. Morales et al. BREAST CANCER RESEARCH AND TREATMENT
- Delayed growth of EL4 lymphoma in SR-A-deficient mice is due to upregulation of nitric oxide and interferon-γ production by tumor-associated macrophages
- (2009) Yoshihiro Komohara et al. CANCER SCIENCE
- Cutting the Limits of Aminobisphosphonates: New Strategies for the Potentiation of their Anti-Tumour Effects
- (2009) M. Marra et al. CURRENT CANCER DRUG TARGETS
- Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
- (2009) Marta Coscia et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts
- (2009) C. L. Roland et al. MOLECULAR CANCER THERAPEUTICS
- Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages
- (2008) Panagiotis Tsagozis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages
- (2008) Koji Hiraoka et al. CANCER SCIENCE
- The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
- (2008) Paola Allavena et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
- (2008) Ilaria Marigo et al. IMMUNOLOGICAL REVIEWS
- Macrophages define the invasive microenvironment in breast cancer
- (2008) Jeffrey W. Pollard JOURNAL OF LEUKOCYTE BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now